This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Leland Stanford Junior University, Massachusetts Institute of Technology. Active years: 2017-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Boston, MA (US) (2017 - 2019)
- Seattle, WA (US) (2021)
Company Filing History:
3 out of 5,512 
2 out of 8,586 
Years Active: 2017-2021
Title: Innovator Byron Hua Kwan: Advancing Cancer Treatment Through Innovative Patents
Introduction: Byron Hua Kwan, an accomplished inventor based in Seattle, WA, has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a remarkable portfolio that includes four patents, Kwan is dedicated to improving therapeutic methods available for various cancer types.
Latest Patents: Among his latest patents are groundbreaking inventions that focus on enhancing cancer treatment methods. The first patent describes a synergistic tumor treatment utilizing an extended pharmacokinetic IL-2 and integrin-binding-Fc fusion protein. This invention provides an effective approach to treating cancer by combining these two mechanisms to target a broad spectrum of cancer types. Another notable patent complements this with methods for treating cancer cells expressing tumor-associated integrins. This patented method integrates extended-PK IL-2, an integrin-binding-Fc fusion protein, and a cancer vaccine, thereby broadening the therapeutic options available for patients fighting against cancer.
Career Highlights: Byron Kwan's professional journey is marked by collaboration with prestigious institutions such as Leland Stanford Junior University and the Massachusetts Institute of Technology. His work at these universities has been instrumental in fostering an environment that encourages innovation and collaboration in cancer research.
Collaborations: Kwan has worked alongside influential researchers in the field, including Karl Dane Wittrup and Jennifer R. Cochran. Their collective efforts have contributed to the development of new and effective cancer therapies, underlining the importance of teamwork in scientific advancement.
Conclusion: As an inventor, Byron Hua Kwan remains at the forefront of innovation in cancer treatment. His patents not only showcase his creative ingenuity but also his commitment to finding solutions for complex medical challenges. With an impressive background and collaborative spirit, Kwan is undoubtedly a significant figure in the pursuit of better therapeutic strategies for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile